InvestorsHub Logo
Followers 17
Posts 671
Boards Moderated 0
Alias Born 12/26/2013

Re: None

Wednesday, 11/06/2019 12:04:58 PM

Wednesday, November 06, 2019 12:04:58 PM

Post# of 5918
What an over reaction. On pace for $290 mil net sales in year 1 when a year ago analysts forecasted first year sales of what $125 mil?

TSC submitting one Jan with expected approval by mid 2020.

Europe launch in full swing beginning 2020.

Sativex sounds like potential approval in early to mid 2021.

Schizo and autism moving forward.

Total Epidiolex sales of maybe $500+mil in 2020? (Probably conservative).

I must be missing something bc it seems like all good news to me.